retatrutide manufacturer Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In ESC 2024: Retatrutide improves lipid

The company has launched Liraglutide Injection (18 mg/3 mL) in the U.S., a bioequivalent version of Victoza by Novo Nordisk

doi: 10.62751/2713-0177-2025-6-3-07

Keep a food journal for a week to track what youre eating, and prioritize nutrient-rich choices like lean protein (aim for about 30g per meal) and high-fiber vegetables

When insulin fluctuations are stabilized, patients often find it easier to make deliberate food choices rather than reacting to rapid shifts in hunger or fatigue

Currently no specific genetic alteration can help to diagnosis MNTI however recently was referred a case with dominant neuroblastic component which showed loss of heterozygosity with deletion of chromosome 1p and gain of chromosome 7q [22]